Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dan Dobreanu

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
Journal of Diabetes|July 4, 2017
Plasma lipids affect dabigatran etexilate anticoagulation in rats with unbalanced diabetes mellitusAlina Scridon, Marcel Perian, Alina MĂrginean, et al.
Journal of Epidemiology and Community Health|November 12, 2024
High long-term mortality in ischaemic heart disease accentuated among ethnic minorities in Eastern Europe: findings from a prospective all-comers percutaneous coronary intervention registry in RomaniaPaul-Adrian Călburean, Paul Grebenișan, Ioana-Andreea Nistor, et al.
Journal of Thrombosis and Haemostasis : JTH|January 18, 2019
Vascular protease-activated receptor 4 upregulation, increased platelet aggregation, and coronary lipid deposits induced by long-term dabigatran administration - results from a diabetes animal modelAlina Scridon, Alina Mărginean, Adina Huțanu, et al.
JACC. Clinical Electrophysiology|September 21, 2019
Sex-Related Procedural Aspects and Complications in CRT Survey II: A Multicenter European Experience in 11,088 PatientsAngelo Auricchio, Maurizio Gasparini, Cecilia Linde, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|January 5, 2018
Patients' knowledge and attitudes regarding living with implantable electronic devices: results of a multicentre, multinational patient survey conducted by the European Heart Rhythm AssociationKristina Hermann Haugaa, Tatjana S Potpara, Serge Boveda, et al.
Journal of Electrocardiology|October 4, 2020
Prognostic significance of a low T/R ratio in Brugada syndromeAntoine Delinière, Adrian Baranchuk, Francis Bessière, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|June 10, 2019
Prediction of ventricular arrhythmias in patients with a spontaneous Brugada type 1 pattern: the key is in the electrocardiogramAntoine Delinière, Adrian Baranchuk, Joris Giai, et al.
European Journal of Heart Failure|September 2, 2022
Dapagliflozin and New York Heart Association functional class in heart failure with mildly reduced or preserved ejection fraction: the DELIVER trialJohn W Ostrominski, Muthiah Vaduganathan, Brian L Claggett, et al.
JAMA Cardiology|May 20, 2023
Association of Dapagliflozin vs Placebo With Individual Kansas City Cardiomyopathy Questionnaire Components in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction: A Secondary Analysis of the DELIVER TrialAlexander Peikert, Alvin Chandra, Mikhail N Kosiborod, et al.
Circulation|March 6, 2023
Patient Characteristics, Outcomes, and Effects of Dapagliflozin According to the Duration of Heart Failure: A Prespecified Analysis of the DELIVER TrialToru Kondo, Karola S Jering, C Jan Willem Borleffs, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
Journal of Diabetes|July 4, 2017
Plasma lipids affect dabigatran etexilate anticoagulation in rats with unbalanced diabetes mellitusAlina Scridon, Marcel Perian, Alina MĂrginean, et al.
Journal of Epidemiology and Community Health|November 12, 2024
High long-term mortality in ischaemic heart disease accentuated among ethnic minorities in Eastern Europe: findings from a prospective all-comers percutaneous coronary intervention registry in RomaniaPaul-Adrian Călburean, Paul Grebenișan, Ioana-Andreea Nistor, et al.
Journal of Thrombosis and Haemostasis : JTH|January 18, 2019
Vascular protease-activated receptor 4 upregulation, increased platelet aggregation, and coronary lipid deposits induced by long-term dabigatran administration - results from a diabetes animal modelAlina Scridon, Alina Mărginean, Adina Huțanu, et al.
JACC. Clinical Electrophysiology|September 21, 2019
Sex-Related Procedural Aspects and Complications in CRT Survey II: A Multicenter European Experience in 11,088 PatientsAngelo Auricchio, Maurizio Gasparini, Cecilia Linde, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|January 5, 2018
Patients' knowledge and attitudes regarding living with implantable electronic devices: results of a multicentre, multinational patient survey conducted by the European Heart Rhythm AssociationKristina Hermann Haugaa, Tatjana S Potpara, Serge Boveda, et al.
Journal of Electrocardiology|October 4, 2020
Prognostic significance of a low T/R ratio in Brugada syndromeAntoine Delinière, Adrian Baranchuk, Francis Bessière, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|June 10, 2019
Prediction of ventricular arrhythmias in patients with a spontaneous Brugada type 1 pattern: the key is in the electrocardiogramAntoine Delinière, Adrian Baranchuk, Joris Giai, et al.
European Journal of Heart Failure|September 2, 2022
Dapagliflozin and New York Heart Association functional class in heart failure with mildly reduced or preserved ejection fraction: the DELIVER trialJohn W Ostrominski, Muthiah Vaduganathan, Brian L Claggett, et al.
JAMA Cardiology|May 20, 2023
Association of Dapagliflozin vs Placebo With Individual Kansas City Cardiomyopathy Questionnaire Components in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction: A Secondary Analysis of the DELIVER TrialAlexander Peikert, Alvin Chandra, Mikhail N Kosiborod, et al.
Circulation|March 6, 2023
Patient Characteristics, Outcomes, and Effects of Dapagliflozin According to the Duration of Heart Failure: A Prespecified Analysis of the DELIVER TrialToru Kondo, Karola S Jering, C Jan Willem Borleffs, et al.
Pageof 5